IMM 1.49% 34.0¢ immutep limited

I would think only for NSCLC as that is the trial that hopefully...

  1. 7,886 Posts.
    lightbulb Created with Sketch. 62
    I would think only for NSCLC as that is the trial that hopefully gets FDA approval. However as an acquisition of IMM then Merck get the full range of every other trial that is underway. If HNSCC trial is successful prior to the NSCLC then that just bumps up the acquisition price.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.005(1.49%)
Mkt cap ! $493.8M
Open High Low Value Volume
33.5¢ 34.0¢ 33.0¢ $1.220M 3.642M

Buyers (Bids)

No. Vol. Price($)
3 57289 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 52306 3
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.